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Summary.-Rats were given a single dose of dimethylnitrosamine (DMN, 20 mg/kg
body weight) alone or 42 or 60 hours after a non-lethal hepatotoxic dose of carbon
tetrachloride (CC14) and killed 12 months later. DMN alone produced no tumours
in the kidney and a few in the liver, but when given 42 hours after CC14, tumours
formed in the kidneys and the number in the liver was increased. When given after
60 hours, the incidence of kidney tumours was less but that of liver tumours was
further increased. A larger dose of DMN (40 mg/kg) was tolerated 42 hours after
CC14 and enhanced the number of kidney and liver tumours, the latter apparently
due to an increased proportion of cholangiomata. Numerous small focal prolifera-
tions of atypical liver cells and of bile duct epithelium were observed after treatment
with DMN. The incidence of these lesions in the different experimental treatments
varied in a similar manner to the liver tumours.
MANY nitroso compounds are acutely
toxic and potently carcinogenic for many
organs and tissues (Magee and Barnes,
1967). Dimethylnitrosamine (DMN) pro-
duced haemorrhagic necrosis in the liver,
haemorrhagic lesions in the lung, haemorr-
hagic ascites and pleural effusions in a
number of animal species (Barnes and
Magee, 1954). On prolonged feeding to
animals, it produced tumours of the liver,
kidneys and other organs (Magee and
Barnes, 1962).
The toxic effects were reduced in
animals given a protein-free diet (McLean
and Verschuuren, 1969) or treated by
other means that reduced the formation of
microsomal enzymes concerned in the
metabolism of DMN (Venkatesan, Arcos
and Argus, 1968; Venkatesan, Argus and
Arcos, 1970; Fiume et al., 1970; Schmahl
et al., 1971; Magour and Nievel, 1971;
Swann and McLean, 1971; Mirvish and
Sidransky, 1971; Somogyi et al., 1972;
Pound, Horn and Lawson, 1973). On the
other hand, a protein-free diet increased
the susceptibility of animals to the carci-
nogenic action ofDMN for the kidneys but
not apparently for the liver (McLean and
Magee, 1970).
The hypothesis that proliferating cells
are more susceptible to the action of a
variety ofchemical carcinogens, was based
on the correlationofthenumnberoftumours
initiated by urethane in proliferating
epidermis with the number of cells in
DNA synthesis, and was supported by an
increased number of tumours of the liver
in mice given urethane or dimethylben-
zanthracene after partial hepatectomy
(Pound, 1968). A similar increase after
partial hepatectomy has been reported in
mice given urethane (Chernozemski and
Warwick, 1970) and in rats given DMN
(Craddock, 1971), and related to the period
of DNA synthesis.
The possibility was raised that the
tumour yield in the liver would be in-
creased if DMN were given in the period
of regeneration that followed a necro-
tizing dose of a hepatotoxin that itself
was not carcinogenic. Carbon tetrachloride
(CC14) produced centrilobular coagulativeA. W. POUND, T. A. LAWSON AND LORRAINE HORN
necrosis in the liver followed by regenera-
tion (Cameron and Karunaratne, 1936;
Hoffman et al., 1955). DNA synthesis
in the remaining liver commenced within
15 hours, followed after a short interval
by active mitosis (Leevy et al., 1959). The
carcinogenicity of CC14 for mice is mani-
fested only in certain susceptible strains
after prolonged and frequent dosage, and
in rats even this weak carcinogenic
action is controversial (Clayson, 1962).
This paper records the occurrence of
tumours ofthe liver and kidney induced in
rats by a single dose of DMN given a
short interval after a single necrosis-
producing dose of CC14.
MATERIALS AND METHODS
Animals-Random bred male Sprague-
Dawley rats were maintained on standard
rat pellets manufactured to a formula
supplied by the Queensland Institute for
Medical Research by Bunge (Australia) Pty
Ltd., Warwick. It contained approximately
20% protein, 4.4% fat, 60% carbohydrate
and fibre, 10% moisture with an added
mineral and vitamin supplement. Water
was supplied adlibitumn. The rats were 12-16
weeks of age and 260-360 g weight at
the beginning of each experiment.
Chemicals. Carbon tetrachloride, A.R.,
was obtained from British Drug Houses Ltd,
Poole, Great Britain. Dimethylnitrosamine
from K. & K. Laboratories, New York, was
redistilled in the laboratory. CC14 was
administered by stomach tube, under light
ether anaesthesia, as 1P5 ml of a solution in
peanut oil. DMN was administered as an
intraperitoneal injection in 1 ml of saline.
Histological methods.-Tissues for histologi-
calexamination werefixedin4% formaldehyde
in buffered saline. The material was pro-
cessed, sections cut and stained by routine
methods.
Experimental.-Rats were treated with
CC14 (2.5 ml/kg). Group 1, 60 rats, received
no further treatment. Group 2, 32 rats,
were given DMN (20 mg/kg) 42 hours after
the dose ofCC14, and Group 3, 35 rats, received
DMN (20 mg/kg) 60 hours after the CC14.
As control groups, 33 rats were set aside with
no treatment. Two groups of 18 rats were
given CC14 (2-5 ml/kg) followed by DMN
(40 mg/kg) 42 and 60 hours laterrespectively.
All rats in the latter group died within 6 days.
The animals were kept for 12 months, the
survivors killed and subjected to autopsy.
The liver and kidneys were examined with
the naked eye for the presence of tumours.
A full longitudinal section of each kidney and
representative full sections of the lobes of the
liver were examined microscopically. Occa-
sionally sections were taken of other tissues.
The few (3-5) rats in each group that died
were ignored, as the deaths appeared to be
due to random factors.
RESULTS
Control animals
None of the 55 surviving rats treated
with CC14 alone, nor of the 33 rats that
had had no treatment, had any lesions
macroscopically or microscopically in the
liver or kidneys. The animals showed
bronchiectasis of varying degrees, with
evidence of chronic infection that is
endemic in this colony. This did not
vary between the treatment groups.
Animals treated with DMN
Animals treated with DMN alone or
DMN after CC14 showed the usual bron-
chiectatic changes; no tumours were seen
in the lungs. A proportion ofthe animals
(Table I) showed tumours or tumour-like
lesions in the liver and kidneys. No other
histological differences were observed in
these organs between the groups of
animals; in particular there was no
evidence of cirrhosis, chronic liver disease
or chronic kidney disease. Since there
appeared to be a correlation between the
incidence ofthe different lesions they were
classified as follows.
Lesions in the Liver
Hepatocellular tumours were charac-
teristic masses of recognizable liver cells
growing in an unco-ordinated fashion,
i.e. not presenting the usual arrangement
of liver cells in plates separated by sinu-
soids, which showed evidence ofexpansive
growth manifested by the thrusting aside
of the surrounding liver cells and growth
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TABLE I.-Number of Tumours and Tumour-like Lesions Found in Rats Treated
with CC14, DMN, or CCl4 Followed by DMN
Liver Hepatocellular
ttumours
Focal proliferationls
Small focal
proliferations
Cholangiomata
Duct proliferatioins
Cysts
Kidney Papillary
adenocarcinoma
Nephroblastoma
DMN 20 mg/kg
-__________-_______ DMSN 40 mg/kg
42 hours after 60 houirs after 42 hours after
DMN only CCl4 CC14 CC14
CC14 Lesions Animals Lesions Animals Lesions Animals
only - , Lesions Animals
0 2 2 3 3 10 7 5 4
0) 4 3 14 9 26 12 28 12
0) 3 3 7 6 8 8 16 11
0
0 0
0 ()
0
0
1
0
3
1
0
3
1
4
6
2
3
5
2
6
20
23
6
12
11
0 0 0 4 4 1 1 17 10
0 0 0 6 3 9
Number of surviving animals 55 27 27 34 17
Thirty-three rats that had no treatment but which were kept for the same time as the experimental
animals constituted controls in which no lesions were found.
by invasion of the adjacent liver tissue
(Fig. 1, 2). The cells forming these
tumours differed in some features from
normal liver cells. A common type
consisted of large cells with pale staining
vacuolated cytoplasm (Fig. 1); another
type consisted of deeper staining rather
less differentiated cells (Fig. 2) but there
were variations of all types between these.
The tumours varied from 5 mm to 3 cm
in diameter. In no rat with these
tumours was a metastatic deposit seen.
Cholangiomata were typical tumours
composed of proliferating cells with the
recognizable morphological characteristics
of bile duct cells, well differentiated into
gland-like spaces between a small amount
of connective tissue stroma. These
tumours varied from 3 to 10 mm in
diameter. No metastatic deposits were
seen. Cysts were usually unilocular and
lined by epithelium resembling that in the
bile ducts.
On microscopic scanning of liver sec-
tions, localized collections of liver cells
from 03to 2-0 mm diameter were observed
scattered randomly through the tissue.
The cytology of the cells forming these
lesions differed from normal. The com-
mon type was composed of pale cells with
finely vacuolated cytoplasm (Fig. 3, 4)
that resembled the cells in the common
type of tumour (Fig. 1). A second type
was composed of darker staining cells
(Fig. 5), and others were composed of
cells of intermediate type. An increased
number of cells with pyknotic nuclei was
seen in these lesions and mitotic figures
were occasionally present, suggesting an
increased rate of cell turnover. These
groups of cells had enlarged by expansion
since the surrounding liver cells were
often thrust aside (Fig. 3, 4). Usually
there was no evidence of invasive growth.
The larger of these lesions (e.g. Fig. 4)
resembled small hepatocellular tumours.
In Table I they are classified as " focal
proliferations ". Smaller and less clearly
defined groups of similar cells were also
frequent, probably of the same nature,
and classified as " small focal prolifera-
tions ".
A further small group of lesions was
also seen in the liver. These consisted of
small groups of irregularly proliferated
bile ducts (Fig. 6).
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FIG. 1.-Photomicrograph ofsection ofhepatocellular tumour 2 cm diameter showing invasive manner
of growth, thrusting aside of adjacent liver due to expansive growth, and cell characteristics of a
common type of tumour. H. and E. x 200.
FIG. 2.-Photomicrograph of section of hepatocellular tumour 1 cm diameter showing invasive
growth, thrusting aside of liver cells due to expansive growth, and cell characteristics of another
type of tumour. H. and E. x 200.
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FIG. 3.-Photomicrograph of section of a focal proliferation of liver cells showing cytological charac-
teristics. There is evidence ofexpansive growth. H. and E. x 120.
F'IG. 4.-Photomicrograph of section of a larger focal proliferation of liver cells showing cell charac-
teristics. There is clear evidence of expansive growth and a suggestion of invasive growth at one
point. The section embraces the whole diameter ofthe lesion. Note similarity of cell type to that in the lesion in Fig. 3 and in the hepatocellular tumour in Fig. 1. H. and E. x 120.
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FIG. 5.-Photomicrograph of section of a focal proliferation of a different cytological type. The
cells are deeper staining and show probable invasion of the surrounding liver. Compare with the
section of the hepatocellular tumour in Fig. 2. H. and E. x 120.
FIG. 6.-Photomicrograph of section of a " duct proliferation " of average size, showing the small
area of atypical proliferation of bile ducts. H. and E. x 120.
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Lesions in the kidneys
The kidney tumours were similar to
those reported by other workers after
administration of DMN and were classi-
fied as either " adenocarcinomata " or
nephroblastoma " (Magee and Barnes,
1962). However, some of the tumours in
the first category appeared to be of a
mixed type (Riopelle and Jasmin, 1969;
Hard and Butler, 1970).
Distribution of lesions in the liver land
kidneys
The numbers of lesions in the liver and
kidneys 12 months after treatment with
DMN are set out in Table I. Tumours
were counted on naked eye examination
and confirmed microscopically. Other
lesions were counted by microscopic
examination of sections of liver about
2 cm2. The number of lesions seen in
sections 5 ,tm thick is regarded as a
measurable parameter of the incidence in
the liver. Statistical data are presented in
Table II.
DMN alone did not produce any kid-
ney tumours in 27 surviving rats, but a
small number oftumours and other lesions
were found in the liver. When the DMN
was given 42 hours after CC14 there was a
significant yield of kidney tumours. The
small increase in number of hepatocellular
tumours is not significant but there is an
increase in the number of focal prolifera-
tions. When DMN was given 60 hours
after CC14 the number of kidney tumours
was less than in the 42-hour group, but
the yield of all types of lesion in the liver
was increased.
When DMN (40 mg/kg) was given 42
hours after CC14 the yield of kidney
tumours was much greater than with the
dose of 20 mg/kg. The yield of hepato-
cellular tumours was not increased
although the yield of focal proliferations
was greater. On the other hand, the
yield of cholangiomata and related types
of duct lesions was increased.
There appears to be a correlation
between the number of hepatocellular
tumours with the number of ' focal
proliferations ". A similar relationship
appears to be likely between the incidence
of cholangiomata and the " duct prolifer-
ations ".
DISCUSSION
After a dose of 2-5 ml/kg of CC14
the level of DMN-demethylase activity
in the liver, upon which the production
of the active intermediate responsible for
the cytotoxic effects of DMN appears to
depend, was greatly reduced for a period
lasting between 42 and 72 hours, but the
activity of this enzyme in the kidney was
not changed (Pound et al., 1973). The
toxic effects of DMN were reduced during
this period and began to return to normal
levels after 60 hours.
The tumour-enhancing effect of CC14
on the kidneys may therefore be explained
as a dose effect, that is, the diminished
rate of metabolism of DMN 42 hours
after CC14 ensured that more DMN was
available to the kidneys and for a longer
time so that more tumours were produced.
After an interval of 60 hours, when the
TABLE II.-Statistical Data on Incidence of Lesions in Table I
DMN 42 hours
after CCI4
Vs
DMIN aloine
DMN 60 hours
after CCI4
Is
DMN 42 houLs
after CC'4
Heptaocellular
tumours
Focal proliferatiOnS
(liver)
Kidney tumouirs
Hepatocellular
tumours
Focal proliferationis
(liver)
Kidnev tuimouirs
Increase
N.S.
Increase
x2 4-.5, 1 (If., P) < 0(.05
Increase
x2 =73, 1 (.f., P < 0-01
Increase
x2= 2-3, 1 d.f., 0-2 > P > 0
Increase
x2 = 1 4, 1 d.f., N.S.
Decrease
x2= 3 63, 1 (I.f., 01 > P > 0.05
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metabolism of DMN by the liver was
returning to normal, the tumour yield
in the kidneys was reduced. The carci-
nogenicity of DMN for kidneys was
strongly dose dependent (Riopelle and
Jasmin, 1963). Rats fed a protein-free
diet which lowered the rate of metabolism
of DMN (Swann and McLean, 1971) can
be given a single large dose of DMN with
a large increase in the tumour yield
(McLean and Magee, 1970; Hard and
Butler, 1970). A similar increase of
kidney tumours was obtained when a
large dose of DMN (40 mg/kg) was
possible under the protecting influence
of CC14 given 42 hours earlier.
The situation regarding the liver is
more complicated. This dose of CC14
(2.5 ml/kg) produced necrosis involving
the inner one-third of the liver lobules,
followed after a period of 24 hours by a
phase of active DNA synthesis which
reached a peak at 42 hours and a second
peak at 60 hours. Mitotic activity was at
a maximum at about 48 hours (Pound
et al., 1973). Thus the DMN was given
at times of maximum DNA synthesis.
Although the diminished rate of metabo-
lism of DMN at 42 hours would impose a
similar dose effect on the liver as on the
kidney, in the liver (unlike in the kidney)
the DMN-demethylase level was depressed.
There is therefore an ambiguity that makes
it difficult to correlate the tumour yields
with any particular phase of cell replica-
tion. Nonetheless, the results are con-
sistent with the view that DMN is a more
effective carcinogen when reacting with
cells synthesizing DNA than with cells
during mitosis, because the tumour yield
was increased at the 42-hour interval
before the peak of mitotic activity, at a
stage when DMN demethylase was
depressed and presumably the active
intermediate less available. The even
greater tumour yield at the 60-hour
interval occurred at a stage when active
DNA synthesis was combined with levels
ofDMN-demethylase returning to normal.
When a larger dose of DMN (40 mg/kg)
was givein 42 hours after CC14 the yield of
hepatocellular tumours was not signifi-
cantly increased although the yield of
focal proliferations was. The production
of hepatocellular tumours may not be
strongly dose dependent. On the other
hand, there was a significant increase in
cholangiomata, duct proliferations and
cysts, but the significance of these distri-
butions needs further investigation.
The present results are of interest
because 12 months after a dose of DMN,
small groups of liver cells of different
morphology and cytology to the surround-
ing normal liver cells were common. The
expansive manner of growth and other
characteristics of these lesions suggest
that they are foci ofliver cells proliferating
independently and possibly arising from
individual cells. It is significant that
the number of these lesions in any experi-
mental situation broadly correlated with
the incidence of tumours. It seems
possible that tumours may arise as a
result of continued growth of these focal
proliferations that is, they are neoplasms
in embryo as it were or alternatively that
they are susceptible to a further change
leading to a neoplastic type of growth.
It is not known ifthese focal proliferations
may be seen soon after a single dose of
DMN, nor is it known if they continue
to grow, remain static in size after a time
or finally regress.
Groups of cells with different morpho-
logy from the surrounding liver cells have
been described in rats given a course of
diethylnitrosamine (DEN) over some days,
soon after the treatment and long before
tumours appeared (Gossner and Friedrich-
Freksa, 1964; Friedrich-Freksa, Gossner
and Borner, 1969). These cells differed
in enzyme constitution from normal
liver cells and resembled those in the
hepatocellular tumours found in animals
that had the same treatment. This
supported their thesis that tumours arise
in or from these lesions. It was also
found that the number of these lesions
was increased when DEN was given after
partial hepatectomy (Scherer and Hoff-
man, 1971). The descriptions and the
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illustrations of these lesions suggest that
they are of the same nature as the focal
proliferations in the present work.
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